JPH0246020B2 - - Google Patents
Info
- Publication number
- JPH0246020B2 JPH0246020B2 JP57200268A JP20026882A JPH0246020B2 JP H0246020 B2 JPH0246020 B2 JP H0246020B2 JP 57200268 A JP57200268 A JP 57200268A JP 20026882 A JP20026882 A JP 20026882A JP H0246020 B2 JPH0246020 B2 JP H0246020B2
- Authority
- JP
- Japan
- Prior art keywords
- cyclodextrin
- isosorbide nitrate
- isosorbide
- nitrate
- clathrate compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229920000858 Cyclodextrin Polymers 0.000 claims description 29
- YWXYYJSYQOXTPL-JGWLITMVSA-N [(3r,3ar,6s,6as)-3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-JGWLITMVSA-N 0.000 claims description 27
- 150000001875 compounds Chemical class 0.000 claims description 18
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 13
- KLDXJTOLSGUMSJ-JGWLITMVSA-N Isosorbide Chemical compound O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-JGWLITMVSA-N 0.000 claims description 3
- 229960002479 isosorbide Drugs 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 10
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 10
- 239000001116 FEMA 4028 Substances 0.000 description 9
- 229960004853 betadex Drugs 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000002441 X-ray diffraction Methods 0.000 description 5
- 238000002411 thermogravimetry Methods 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- -1 Isosorbide nitrate ester Chemical class 0.000 description 4
- 238000004455 differential thermal analysis Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 229960003827 isosorbide mononitrate Drugs 0.000 description 2
- YWXYYJSYQOXTPL-SLPGGIOYSA-N isosorbide mononitrate Chemical compound [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-SLPGGIOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- WQZGKKKJIJFFOK-UHFFFAOYSA-N alpha-D-glucopyranose Natural products OCC1OC(O)C(O)C(O)C1O WQZGKKKJIJFFOK-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000010587 phase diagram Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006190 sub-lingual tablet Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000007939 sustained release tablet Substances 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57200268A JPS5993032A (ja) | 1982-11-17 | 1982-11-17 | 安定なイソソルビド硝酸エステルの包接化合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57200268A JPS5993032A (ja) | 1982-11-17 | 1982-11-17 | 安定なイソソルビド硝酸エステルの包接化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5993032A JPS5993032A (ja) | 1984-05-29 |
| JPH0246020B2 true JPH0246020B2 (es) | 1990-10-12 |
Family
ID=16421501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57200268A Granted JPS5993032A (ja) | 1982-11-17 | 1982-11-17 | 安定なイソソルビド硝酸エステルの包接化合物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5993032A (es) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5692221A (en) * | 1979-12-26 | 1981-07-25 | Zeria Shinyaku Kogyo Kk | Stable clathrate compound of trolnitrate, and its preparation |
-
1982
- 1982-11-17 JP JP57200268A patent/JPS5993032A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5692221A (en) * | 1979-12-26 | 1981-07-25 | Zeria Shinyaku Kogyo Kk | Stable clathrate compound of trolnitrate, and its preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5993032A (ja) | 1984-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69115229T2 (de) | Arzneimittel. | |
| JP4104687B2 (ja) | Ｃｄｃｈの新規な結晶変態、その製造法及びこの変態を含む製薬学的調剤 | |
| KR910004338B1 (ko) | 에어로졸로 사용하기 적합한, 물리적 변성 베클로메타손 디프로피오네이트 | |
| DK174429B1 (da) | Fast natriumnedocromil indeholdende bundet vand samt farmaceutisk præparat indeholdende det faste natriumnedocromil | |
| NZ204929A (en) | Pharmaceutical compositions containing alpha(3-chloro-4-(3-pyrrolin-1-yl)-phenyl)propionic acid and a cyclodextrin | |
| JP2650807B2 (ja) | 複素環式化合物 | |
| HUT59821A (en) | Macrograin aerosole carriers and process for producing them | |
| EA011275B1 (ru) | Суточная дозированная единица комплекса этинилэстрадиол-циклодекстрин | |
| HU194285B (en) | Process for preparing inclusion compound formed from 2-/nitrooxymethyl/-6-chlorpyridine and beta-cyclodextrin | |
| EP1765843B1 (en) | Process for preparing a pulverulent alditol acetal composition | |
| JPH032154B2 (es) | ||
| JPH0246020B2 (es) | ||
| HU226221B1 (en) | Milling process for the production of finely milled medicinal substances | |
| EP0088958B1 (en) | Stabilization of azulene derivatives | |
| JPS5835967B2 (ja) | 微細結晶ワルフアリンの製造方法 | |
| EP0088382B1 (en) | Stabilization of azulene derivatives | |
| WO1991014680A1 (en) | Inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine or salts formed with cyclodextrin derivatives, preparation thereof and pharmaceutical compositions containing the same | |
| US2583559A (en) | Tetraglycine dihydroheptiodide and methods of making the same | |
| WO2001068587A1 (fr) | Nouveau derive de cristal de stilbene et son procede d'obtention | |
| WO1994002177A1 (en) | Method of preparation of inclusion compounds of nimesulide with cyclodextrins | |
| JPH1087455A (ja) | 錯形成剤を有するシェービングエイド | |
| US20080091006A1 (en) | Nitrate ester cyclodextrin complexes | |
| JP3403468B2 (ja) | アスコルビン酸−２−リン酸エステルマグネシウム塩の製造法及びその塩を含有する化粧料 | |
| CH697008A5 (de) | Verfahren zur Stabilisierung von Alkylamiden, Ketoalkenen und Ketoalkynen. | |
| JP3690343B2 (ja) | 溶状安定化アスコルビン酸−２−リン酸エステルマグネシウム塩及びその製造方法 |